![Peter Emtage](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Peter Emtage
Oprichter bij
Santa Ana Bio, Inc.
Profiel
Peter Emtage is the founder of Santa Ana Bio, Inc. Dr. Emtage is currently a Venture Partner at Versant Venture Management LLC since 2021.
Formerly, Dr. Emtage was Director at Kyverna Therapeutics, Inc., Vice President-Immunotherapy at MedImmune LLC, Vice President-Research & Development at Nventa Biopharmaceuticals Corp., Vice President-Synthetic Immunology at Precigen, Inc., and Chief Scientific Officer at Femta Pharmaceuticals, Inc. Dr. Emtage completed undergraduate and graduate degrees at the University of Guelph and earned a doctorate from McMaster University.
Actieve functies van Peter Emtage
| Bedrijven | Functie | Begin |
|---|---|---|
Versant Venture Management LLC
 Versant Venture Management LLC Investment ManagersFinance Versant Ventures invests in biotechnology companies located globally. The firm participates in early and later stage capital requirements. | Private Equity Investor | 01-10-2020 |
Santa Ana Bio, Inc.
 Santa Ana Bio, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which focuses on precision immunology for autoimmune diseases | Oprichter | - |
Eerdere bekende functies van Peter Emtage
| Bedrijven | Functie | Einde |
|---|---|---|
| KYVERNA THERAPEUTICS, INC. | Directeur/Bestuurslid | 26-01-2022 |
MedImmune LLC
 MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Corporate Officer/Principal | - |
Femta Pharmaceuticals, Inc.
 Femta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops antibody therapeutics | Hoofd Techniek/Wetenschap/O&O | - |
| PRECIGEN, INC. | Corporate Officer/Principal | - |
Nventa Biopharmaceuticals Corp.
 Nventa Biopharmaceuticals Corp. Medical SpecialtiesHealth Technology Discovers, develops and commercializes innovative stress protein-based therapeutic vaccines | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Peter Emtage
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
8
Eerstegraads connecties
9
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 9 |
|---|---|
MedImmune LLC
MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Nventa Biopharmaceuticals Corp.
Nventa Biopharmaceuticals Corp. Medical SpecialtiesHealth Technology Discovers, develops and commercializes innovative stress protein-based therapeutic vaccines | Health Technology |
Precigen, Inc.
 Precigen, Inc. BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company | Health Technology |
University of Guelph
 University of Guelph Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
McMaster University
 McMaster University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Versant Venture Management LLC
Versant Venture Management LLC Investment ManagersFinance Versant Ventures invests in biotechnology companies located globally. The firm participates in early and later stage capital requirements. | Finance |
Femta Pharmaceuticals, Inc.
Femta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops antibody therapeutics | Health Technology |
Kyverna Therapeutics, Inc.
 Kyverna Therapeutics, Inc. BiotechnologyHealth Technology Operates as a cell therapy company which develops treatments and potential cures for serious autoimmune diseases | Health Technology |
Santa Ana Bio, Inc.
Santa Ana Bio, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which focuses on precision immunology for autoimmune diseases | Health Technology |
